Trial · NCT04894266
An Open-Label Study of Apabetalone in Covid Infection
NCT04894266, Phase 2, Phase 3, Terminated, Resverlogix Corp
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. An Open-Label Study of Apabetalone in Covid Infection. Trials, record NCT04894266. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04894266
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- An Open-Label Study of Apabetalone in Covid Infection
- NCT number
- NCT04894266
- Status
- Terminated
- Phases
- Phase 2, Phase 3
- Enrollment
- 1 participants, actual
- Lead sponsor
- Resverlogix Corp
- Conditions
- COVID-19 Infection
- Interventions
- Apabetalone, Standard of care
- First posted
- 2021-05-20
- Last updated
- 2023-11-18
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The primary endpoint of the study is the change in WHO Ordinal Scale for Clinical Improvement at Day 14 | Change in WHO Ordinal Scale for Clinical Improvement at Day 14 | WHO Ordinal Scale for Clinical Improvement, 8 point scale, 0 = no clinical or virological evidence of infection |
| Secondary | Change in WHO Ordinal Scale for Clinical Improvement at Day 28 | Study Day 28 | WHO Ordinal Scale for Clinical Improvement, 8 point scale, 0 = no clinical or virological evidence of infection |
| Secondary | Biomarkers of inflammation Interleukin-6 | Study Day 28 | Interleukin-6 is a biomarker of inflammation |
| Secondary | Total time of hospitalization | through study completion, an average of 28 days | Total time of hospitalization |
| Secondary | Biomarkers of inflammation Interleukin-8 | Study Day 28 | Interleukin-8 is a biomarker of inflammation |
| Secondary | Biomarkers of inflammation Tumor Necrosis Factor alpha | Study Day 28 | Tumor Necrosis Factor alpha is a biomarker of inflammation |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04894266
GET https://conductscience.org/api/trials/v1/NCT04894266/registered